LIVN Stock Analysis

LivaNova PLC
HEALTHCARE MEDICAL DEVICES

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
B-
70.32 / 100
Strong
Confidence: Very High (100.0%) Coverage: 100.0%
Business Quality 41.3
Financial Strength 75.2
Earnings & Growth 90.3
Valuation 73.2
Market Strength 81.7
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend STRONG BUY TREND
Bullish
The available trend signal is constructive.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio 23.93
Moderate
Not cheap, but not extremely expensive.
P/E shows how much investors pay for each dollar of earnings.
ROIC -14.49%
Poor
Negative ROIC suggests capital is not being used profitably.
ROIC measures how efficiently capital turns into profit.
Debt Payback 1.99 yrs
Strong
Under 3 years is generally a strong balance-sheet sign.
Debt payback estimates how quickly debt could be covered.
Interest Coverage 4.05x
Caution
Coverage is acceptable but leaves less cushion.
Interest coverage shows how easily earnings cover interest costs.
Price $80.90
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-25 23:54:17

Performance Overview

Trailing adjusted-close returns as of 2026-07-16. Benchmark is SPY.

YTD Return

LIVN +32.93%
SPY +10.68%

1-Year Return

LIVN +90.25%
SPY +21.59%

3-Year Return

LIVN +55.49%
SPY +73.45%

5-Year Return

LIVN +5.26%
SPY +86.25%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

50%
EPS Strength
PASS

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
PASS

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
FAIL

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
STRONG BUY TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA77.22
50-Day MA78.51
200-Day MA72.46
MA Score5

Latest Published Stock Research

Research generated: October 25, 2026

LIVN Stock Analysis: Why LivaNova PLC Scored 50% in Stock Value Finder

Analyzing LivaNova PLC (LIVN): An Educational Research Review

Welcome to this detailed stock research report on LivaNova PLC (LIVN). This article serves as an educational review provided by StockValueFinder.com. Our goal is to move beyond simple "buy" or "sell" labels and instead teach investors how to dissect a company's financial health using specific metrics. By examining LivaNova PLC, we can explore the tension between technical price trends and fundamental financial health.

LivaNova PLC operates within the Healthcare sector, specifically in the Medical Devices industry. For investors, the medical device space is often characterized by high research and development costs and strict regulatory environments. To determine if a company in this sector is a sound investment, we must look at how efficiently it uses its capital, how it manages its debt, and whether the current market price reflects a fair value.

Why the StockValueFinder Score Matters

When evaluating a stock, it is easy to get overwhelmed by a sea of numbers. The StockValueFinder score is designed to synthesize multiple fundamental and technical tests into a single percentage to provide a snapshot of a company's overall profile.

LivaNova PLC (LIVN) currently holds a StockValueFinder score of 50%. In our system, a score of 50% indicates a neutral or mixed profile where some strengths are offset by significant weaknesses. Based on this score and the accompanying fundamental failures, the current rating for LIVN is AVOID.

An "AVOID" rating does not necessarily mean a company is failing, but rather that it does not currently meet the strict criteria for a high-quality, value-oriented investment. For educational purposes, a high-scoring stock typically passes the majority of its fundamental tests (EPS, ROIC, Interest Coverage, Debt Payback, and P/E Valuation) while simultaneously showing a positive technical trend. LivaNova passes some of these tests but fails others, leading to its current rating.

EPS Strength and Consistency

The first pillar of our analysis is Earnings Per Share (EPS). EPS represents the portion of a company's profit allocated to each outstanding share of common stock. It is a primary indicator of a company's ability to generate profit for its shareholders.

For LivaNova PLC, the EPS test is marked as Passed. While the specific historical EPS figures were not supplied for this report, the StockValueFinder system recorded a "Pass" based on the available data.

From an educational standpoint, consistency in EPS is more important than a single year of high growth. A company that grows its earnings steadily over five to ten years is generally viewed as lower risk than a company with volatile earnings that swing from profit to loss. For example, if Company A earns $1.00, $1.10, and $1.20 per share over three years, it shows a predictable growth trajectory. If Company B earns $2.00, then loses $0.50, then earns $1.00, it is considered inconsistent, even if the average is similar. LivaNova's "Pass" suggests that its earnings profile meets the minimum requirements for stability and growth required by our screen.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is perhaps the most critical metric for determining if a company is actually creating value. ROIC measures how much profit a company generates for every dollar of capital it puts to work (including both debt and equity).

LivaNova PLC has a reported ROIC of -14.49%. Consequently, the ROIC test did not pass.

To understand why this is a failure, we must look at the benchmarks. StockValueFinder generally prefers an ROIC of 10% or higher. A positive ROIC indicates that the company is earning more on its investments than the cost of the capital it used to fund those investments. A negative ROIC, such as -14.49%, suggests that the company is currently losing value on the capital it has deployed.

To illustrate this for other stocks: imagine Company X has an ROIC of 15%, while Company Y has an ROIC of 4%. Company X is significantly more efficient; it is generating 15 cents of profit for every dollar invested, whereas Company Y is barely breaking even. When a company has a negative ROIC, it is a red flag that the business model may be struggling or that the company has overpaid for acquisitions that are not yet producing returns.

Interest Coverage and Financial Safety

While a company may be growing, it must be able to afford the cost of its debt. The interest coverage ratio tells us how many times over a company can pay its interest expenses using its operating income.

The interest coverage test for LivaNova PLC did not pass. Although the exact ratio was not supplied, the failure indicates that the company's earnings are not sufficiently high relative to its interest obligations to meet our safety threshold.

StockValueFinder prefers an interest coverage ratio of 6 or higher. This provides a "margin of safety." If a company's income drops unexpectedly, a high coverage ratio ensures they can still pay their lenders without risking bankruptcy. For example, a company with 8x coverage is in a very healthy position; even if their income dropped by 50%, they could still easily cover their interest. A company with 2x coverage is in a precarious position; a small dip in revenue could leave them unable to meet their debt obligations. LivaNova's failure here suggests a higher level of financial risk.

Debt Payback and Balance Sheet Discipline

While interest coverage looks at the immediate ability to pay interest, the Debt Payback metric looks at the total debt load. This metric estimates how many years it would take for a company to pay off its total debt using its current annual free cash flow.

LivaNova PLC has a debt payback period of 1.99 years. Because of this, the debt payback test Passed.

StockValueFinder considers a debt payback period of 3 years or less to be attractive. This indicates that the company is not overburdened by its total debt relative to the cash it generates. To put this in perspective, a company that can pay off its entire debt in 1.5 years is in a much stronger position than a company that would take 7 years to do so. The latter is much more vulnerable to interest rate hikes or economic downturns. LivaNova’s 1.99-year payback is a notable strength in an otherwise mixed financial profile.

P/E Ratio and Valuation Discipline

A company can have great fundamentals, but if you pay too much for the stock, your potential for profit decreases. The Price-to-Earnings (P/E) ratio helps investors determine if a stock is overvalued or undervalued.

LivaNova PLC has a P/E ratio of 23.93. Because of this, the P/E valuation test did not pass.

For the sake of valuation discipline, StockValueFinder prefers a P/E ratio of 15 or lower. A lower P/E generally means you are paying less for every dollar of earnings the company produces. For example, if Stock A has a P/E of 8 and Stock B has a P/E of 40, Stock A is more "value-oriented." While a high P/E can sometimes be justified by massive growth expectations, our system prioritizes a margin of safety. At 23.93, LivaNova is trading at a premium that exceeds our strict value criteria.

Moving Average Trend and Entry Timing

Fundamental analysis tells us *what* to buy, but technical analysis helps us understand *when* to buy. We use moving averages to identify the current momentum of the stock price.

LivaNova PLC currently shows a "STRONG BUY TREND" according to its moving average signal. This means the stock price is currently trending upward, which often attracts momentum traders. However, it is important to remember that a trend signal is a tool for timing discipline, not a guarantee that the stock must continue to rise.

Regarding specific entry points, the following data was supplied

Entry signal: N/A - Entry status: N/A - Limit buy idea: N/A - Pullback zone: N/A - Risk stop / trend risk level: N/A

In an educational context, these "N/A" values mean that the system has not identified a specific, low-risk entry window. A "pullback zone" would be a price range where the stock has dropped slightly from its peak but remains in an uptrend, offering a better value. A "risk stop" is a price level where, if the stock falls below it, the upward trend is considered broken. Without these levels, an investor is essentially chasing the current trend without a defined safety net.

Overall Financial Strengths and Weaknesses

To summarize the research on LivaNova PLC (LIVN), we can weigh the passing metrics against the failing ones.

**Strengths:** - **Debt Management:** With a debt payback period of 1.99 years, the company manages its total debt load efficiently. - **Earnings Stability:** The company passed the EPS test, suggesting a baseline of earnings consistency. - **Price Momentum:** The "STRONG BUY TREND" indicates that the market is currently pushing the price higher (Recent price: $80.90).

**Weaknesses:** - **Capital Inefficiency:** The ROIC of -14.49% is a significant concern, showing that the company is not generating a positive return on its invested capital. - **Financial Safety:** The failure of the interest coverage test suggests that the company's earnings are not comfortably covering its interest payments. - **Valuation:** A P/E of 23.93 is higher than the preferred threshold of 15, meaning the stock is not currently priced as a "value" play.

Risks and Limitations

Investing in medical device companies like LivaNova involves specific risks. When a company has a negative ROIC and fails its interest coverage test, it is more susceptible to external shocks. If the healthcare sector faces new regulatory hurdles or if interest rates rise, companies with weak interest coverage may struggle to maintain their operations without taking on more expensive debt.

Furthermore, the disconnect between the "STRONG BUY TREND" and the "AVOID" rating highlights a common market phenomenon: price momentum can often diverge from fundamental value. A stock can go up in price even if its fundamentals are weak, but this creates a risk of a sharp correction if the market suddenly refocuses on the company's actual financial health.

Educational Conclusion

LivaNova PLC (LIVN) presents a classic case study in the importance of holistic analysis. If an investor looked only at the moving average, they would see a "STRONG BUY TREND" and might be tempted to enter the position. However, by applying the StockValueFinder screen, we see a different story.

The company is efficient at paying down its total debt (Debt Payback: 1.99 years), but it is struggling to generate a return on its capital (ROIC: -14.49%) and lacks a comfortable cushion for its interest payments. When combined with a P/E ratio (23.93) that exceeds value benchmarks, the overall profile results in a 50% score and an AVOID rating.

The lesson for the student of investing is clear: do not rely on a single metric. A strong price trend is not a substitute for a healthy balance sheet, and a low debt payback period cannot offset a negative return on invested capital. True quality is found when the technical trend aligns with strong, efficient, and reasonably priced fundamentals.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Omar Gemani

Specializing in global financial markets, macroeconomic trends, and equity valuation, Omar Gemani brings a disciplined, research-driven perspective to investment analysis. His editorial approach emphasizes company fundamentals, earnings sustainability, financial strength, and long-term growth potential. Combining fundamental analysis with broader economic indicators, Omar evaluates investment opportunities while highlighting market uncertainty, valuation risks, and the importance of capital preservation.

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top